Significantly, these effects were abolished by silencing IGF2R expression in macrophages and fibroblasts or IGF2 in cancer cells, indicating that the IGF2/IGF2R interaction played a pivotal role in mediating these effects and suggesting that IGF2 or STAT3 could represent suitable co-targets in combination with IGF1R blockade. The gene discussed is STAT3; the disease is cancer.